Age-Dependent Hepatic Enzyme Abundance and Capacity

From Enzyme Quantity to Metabolic Capacity

A developmental abundance profile does not, by itself, specify how quickly a drug is metabolized. Enzyme abundance describes how much enzyme is present; catalytic activity describes the reaction rate that enzyme can produce under specified conditions. Metabolic capacity depends on both, as well as on the amount of enzyme-containing tissue. Keeping these quantities distinct is essential when translating age-dependent biology into a PBPK parameter.

For a hepatic enzyme, an age-related change in protein abundance can change the liver’s total capacity even if each enzyme molecule functions identically at every age. Conversely, equal measured abundance does not guarantee equal capacity if the active fraction, catalytic rate, or substrate affinity differs. The calculation below makes these components explicit rather than treating an abundance fraction as if it were clearance.

Definition: Enzyme abundance is the amount of enzyme protein, expressed on a stated basis such as amount per milligram of microsomal protein. Catalytic activity is the rate of reaction under specified assay conditions. Intrinsic clearance is the rate of metabolism divided by the unbound drug concentration at the enzyme, under conditions where that ratio is defined. Metabolic capacity is the total potential metabolic rate of the relevant enzyme-containing tissue; it depends on enzyme amount and catalytic properties.

Why Abundance and Activity Are Different

For a single enzyme following Michaelis–Menten kinetics, the rate of metabolism is

v = \frac{V_{\max} C_u}{K_m+C_u}, \qquad V_{\max}=k_{\mathrm{cat}}E_{\mathrm{active}}.

Here $v$ is the metabolic rate, $C_u$ is the unbound substrate concentration at the enzyme, $K_m$ is the concentration giving half of $V_{\max}$, $k_{\mathrm{cat}}$ is the turnover rate per active enzyme molecule, and $E_{\mathrm{active}}$ is the amount of active enzyme. Total measured enzyme protein can exceed $E_{\mathrm{active}}$ if some protein is inactive. At concentrations well below $K_m$, the rate is approximately proportional to concentration, and the unbound intrinsic clearance is

CL_{\mathrm{int},u} \approx \frac{v}{C_u} = \frac{V_{\max}}{K_m} = \frac{k_{\mathrm{cat}}E_{\mathrm{active}}}{K_m}.

Thus, at low substrate concentration, a change in abundance changes intrinsic clearance in direct proportion only if the active fraction, $k_{\mathrm{cat}}$, and $K_m$ are unchanged. If $K_m$ changes, catalytic efficiency changes even when enzyme amount does not. At concentrations near or above $K_m$, the rate is no longer proportional to concentration; a single linear intrinsic-clearance value is then not enough to describe the reaction across concentrations.

Worked Example: Separating Abundance From Catalytic Efficiency

Suppose a hypothetical assay estimates that adult liver contains 100 pmol of active enzyme per gram of liver, with $k_{\mathrm{cat}}=0.50\ \mathrm{min}^{-1}$ and $K_m=2.0\ \mathrm{\mu M}$. At a specified pediatric age, the corresponding values are 45 pmol/g, $0.60\ \mathrm{min}^{-1}$, and $2.5\ \mathrm{\mu M}$. Compare maximum capacity per gram and low-concentration intrinsic clearance per gram.

For the adult, $V_{\max}=0.50\times100=50\ \mathrm{pmol\,min^{-1}\,g^{-1}}$. For the child, $V_{\max}=0.60\times45=27\ \mathrm{pmol\,min^{-1}\,g^{-1}}$. The child’s enzyme amount is 45% of the adult value, but maximum capacity is 54% of the adult value because the hypothetical catalytic turnover per active molecule is higher.

At low substrate concentration, the adult value is $50/2.0=25$ in units of rate per concentration per gram of liver, while the child’s value is $27/2.5=10.8$ in the same units. The ratio is $10.8/25=0.432$, or 43.2%. The child therefore has 54% of adult maximum capacity per gram but 43.2% of adult low-concentration intrinsic clearance per gram. Those are different comparisons because intrinsic clearance also depends on $K_m$.

These values are hypothetical and illustrate the calculation, not an age-specific enzyme profile. The example also shows why an abundance ratio alone cannot establish either $V_{\max}$ or intrinsic clearance unless the relevant catalytic properties are assumed or measured.

Scaling Capacity From Microsomes to the Liver

A common in vitro input is unbound intrinsic clearance per milligram of liver microsomal protein. To obtain whole-liver capacity, that value must be scaled by the amount of microsomal protein per gram of liver and by liver mass. If the input is an adult reference value, the age-specific abundance and catalytic-efficiency factors can then adjust it, provided those factors are defined on compatible bases.

Scaling relation: If the reference value is adult in vitro unbound intrinsic clearance per milligram of microsomal protein, a low-concentration whole-liver estimate at age $a$ is $$ CL_{\mathrm{int},u,\mathrm{liver}}(a) = \frac{ CL_{\mathrm{int},u,\mathrm{inc,adult}}\, MPPGL(a)\, M_{\mathrm{liver}}(a)\, A(a)\, K(a) }{1000}. $$ Here $MPPGL(a)$ is microsomal protein per gram of liver, $M_{\mathrm{liver}}(a)$ is liver mass in grams, $A(a)$ is enzyme abundance per milligram of microsomal protein relative to the adult reference, and $K(a)$ is the age-to-adult ratio in catalytic efficiency per unit enzyme, including the relevant $k_{\mathrm{cat}}/K_m$ change at low concentration. If clearance is in $\mathrm{\mu L/min/mg}$, this formula gives whole-liver clearance in $\mathrm{mL/min}$. Use $A(a)=K(a)=1$ for the adult reference.

The factor of 1000 converts microlitres to millilitres. The relation assumes the in vitro value is appropriate for the enzyme and substrate of interest, the microsomal protein and liver-mass inputs correspond to the same age, and the reaction is in the low-concentration regime. It also assumes abundance is measured per milligram of microsomal protein. If abundance is already represented by an age-specific measured clearance per milligram, applying $A(a)$ again would count the same age effect twice.

This calculation concerns whole-liver intrinsic capacity, not hepatic clearance from blood. To illustrate the distinction, the well-stirred liver model relates blood flow and intrinsic clearance as

CL_H(a)= \frac{Q_H(a)\,f_{u,b}(a)\,CL_{\mathrm{int},u,\mathrm{liver}}(a)} {Q_H(a)+f_{u,b}(a)\,CL_{\mathrm{int},u,\mathrm{liver}}(a)}.

Here $Q_H$ is hepatic blood flow and $f_{u,b}$ is the unbound fraction in blood. This model assumes a well-mixed liver and uses compatible blood-based units. The age-specific organ-mass and blood-flow quantities should be consistent with the earlier material on scaling organ mass and blood flow during growth. The result is bounded above by $Q_H$; intrinsic capacity and hepatic clearance are not interchangeable.

Worked Example: Scaling Adult In Vitro Clearance to Three Ages

Consider hypothetical values for an enzyme with adult in vitro clearance of $12\ \mathrm{\mu L/min/mg}$ microsomal protein. Use the following inputs: adult $MPPGL=40\ \mathrm{mg/g}$, liver mass $1500\ \mathrm{g}$, $A=1.00$, and $K=1.00$; age 2 years $MPPGL=35\ \mathrm{mg/g}$, liver mass $600\ \mathrm{g}$, $A=0.60$, and $K=0.90$; newborn $MPPGL=20\ \mathrm{mg/g}$, liver mass $180\ \mathrm{g}$, $A=0.20$, and $K=0.80$. Calculate whole-liver intrinsic clearance at each age.

For the adult, $12\times40\times1500/1000=720\ \mathrm{mL/min}$. For the 2-year-old, $12\times35\times600/1000=252\ \mathrm{mL/min}$ before the abundance and catalytic-efficiency adjustments. Applying both gives $252\times0.60\times0.90=136.08\ \mathrm{mL/min}$, or $136.1\ \mathrm{mL/min}$.

For the newborn, the unadjusted value is $12\times20\times180/1000=43.2\ \mathrm{mL/min}$. The adjusted value is $43.2\times0.20\times0.80=6.912\ \mathrm{mL/min}$. The estimates are therefore 720, 136.1, and 6.912 $\mathrm{mL/min}$ for the adult, 2-year-old, and newborn, respectively.

The differences reflect liver size, microsomal protein per gram, abundance per milligram of microsomal protein, and catalytic efficiency. The calculation does not imply that any one of these hypothetical values is typical of a real enzyme or age group.

From Intrinsic Capacity to Hepatic Clearance

The next calculation uses those hypothetical intrinsic clearances to show why a lower intrinsic capacity does not translate into the same proportional reduction in hepatic clearance at every age. Suppose, purely for illustration, that $f_{u,b}=0.50$ at all three ages and that hepatic blood flows are 900, 100, and 30 $\mathrm{mL/min}$ for the adult, 2-year-old, and newborn.

Worked Example: Comparing Hepatic Clearance Across Ages

Apply the well-stirred relation to the intrinsic clearances calculated above. For the adult, $f_{u,b}CL_{\mathrm{int},u}=0.50\times720=360\ \mathrm{mL/min}$, so

CL_H=\frac{900\times360}{900+360} =\frac{324000}{1260} =257.1\ \mathrm{mL/min}.

For the 2-year-old, $f_{u,b}CL_{\mathrm{int},u}=0.50\times136.08=68.04\ \mathrm{mL/min}$, giving

CL_H=\frac{100\times68.04}{100+68.04} =\frac{6804}{168.04} =40.49\ \mathrm{mL/min}.

For the newborn, $f_{u,b}CL_{\mathrm{int},u}=0.50\times6.912=3.456\ \mathrm{mL/min}$, giving

CL_H=\frac{30\times3.456}{30+3.456} =\frac{103.68}{33.456} =3.099\ \mathrm{mL/min}.

These hypothetical hepatic clearances are below their corresponding blood flows, as the model requires. Their ratios to adult clearance are not simply the ratios of intrinsic clearances: blood flow also differs, and the model is nonlinear in intrinsic capacity. A PBPK model should therefore pass the age-specific intrinsic clearance into the hepatic model rather than substituting it directly for $CL_H$.

Assumptions, Diagnostics, and Common Pitfalls

The scaling relation is useful when its inputs describe distinct biological quantities and the assay supports the chosen kinetic approximation. Before relying on a result, check that the abundance measure is normalized as expected, the catalytic factor is not already embedded in the in vitro clearance, and all conversions preserve units. A calculated whole-liver capacity should have units of volume per time; a value retaining units per milligram signals that tissue scaling is incomplete.

A second diagnostic is biological consistency. If age-specific abundance rises while predicted capacity falls sharply, inspect whether the catalytic-efficiency factor, microsomal protein per gram, or liver mass explains the direction. Such a result is possible, but it should not arise from an unnoticed reversal of an age ratio or an inconsistent reference. When activity data are available, compare predicted and measured activity rather than assuming protein abundance is a direct surrogate.

There are two main approaches to representing age dependence. One scales an adult in vitro value using age-specific tissue scaling, abundance, and catalytic-efficiency factors; this is transparent when those components are separately available. The other uses directly measured age-specific activity or intrinsic clearance, which can capture several effects together but may be sparse, noisy, or assay-dependent. In the second approach, do not apply an additional abundance factor if the measured value already includes the abundance difference. Neither approach removes uncertainty in the underlying measurements.

The calculation also has limits. A single low-concentration intrinsic clearance is inappropriate when substrate concentrations approach enzyme saturation. Microsomal measurements may not represent all hepatic enzymes or the in vivo environment, and protein abundance assays may not distinguish active from inactive enzyme. The well-stirred model adds assumptions about mixing and blood-based inputs; it does not correct errors in the intrinsic-clearance estimate. These calculations establish how capacity may be translated, not which developmental profile applies to a particular enzyme.

Common pitfall: Multiplying adult intrinsic clearance by an abundance fraction and calling the result “pediatric hepatic clearance” skips tissue scaling and the liver model. The abundance fraction adjusts enzyme amount only on its stated normalization basis. First scale to whole-liver intrinsic capacity, account for catalytic properties, and then use the appropriate hepatic clearance relation.

Check the assay quantity.
Identify whether the input is abundance, activity, $V_{\max}$, or intrinsic clearance, and note its units and normalization basis.

Specify the kinetic regime.
Use $V_{\max}/K_m$ as the low-concentration relation only when substrate concentration is well below $K_m$.

Scale once to the liver.
Combine microsomal protein per gram, liver mass, and any age effects not already included in the assay value.

Calculate hepatic clearance separately.
Use age-appropriate blood flow and unbound fraction with whole-liver intrinsic clearance, and check that $CL_H$ does not exceed $Q_H$.

Check Your Understanding

Answer each question, then compare with the short solutions below.

If enzyme abundance per milligram of microsomal protein is 70% of adult, under what conditions is low-concentration intrinsic clearance per milligram also 70% of adult?
A hypothetical assay reports $8\ \mathrm{\mu L/min/mg}$, with $MPPGL=30\ \mathrm{mg/g}$ and liver mass $400\ \mathrm{g}$. With $A=0.50$ and $K=1.00$, calculate whole-liver intrinsic clearance in $\mathrm{mL/min}$.
Why can two ages with the same enzyme abundance have different low-concentration intrinsic clearance?
In the well-stirred model, can hepatic clearance exceed hepatic blood flow? State the model implication.
What error occurs if an age-specific in vitro intrinsic-clearance value already includes lower enzyme abundance and the same abundance fraction is applied again?

Solutions. 1. When the active fraction, catalytic efficiency per enzyme molecule, and relevant assay conditions are unchanged, and abundance is measured on the same microsomal-protein basis. 2. $8\times30\times400/1000=96\ \mathrm{mL/min}$ before age adjustment; $96\times0.50\times1.00=48\ \mathrm{mL/min}$. 3. Their active fractions, $k_{\mathrm{cat}}$, or $K_m$ may differ; at low concentration, clearance depends on $k_{\mathrm{cat}}E_{\mathrm{active}}/K_m$. 4. No. The well-stirred equation gives $CL_H=Q_H x/(Q_H+x)$ for positive $x=f_{u,b}CL_{\mathrm{int},u}$, which is less than $Q_H$. 5. The abundance effect is counted twice, causing an artificially low capacity estimate.